MORE►
UT Dallas Magazine
Dr. A. Dean Sherry [Photo: UT Dallas]
The Last Word: Macrocyclics Founder Dr. A. Dean Sherry on His Company’s Impact on Nuclear Medicine
by Dallas Innovates | Staff Report | Jul 14, 2023
A holder of 34 patents, Sherry was a pioneer in designing molecular materials for use in medical imaging. His work on chemicals called macrocyclic ligands led to their use in carrying "a payload of metallic radiotherapeutic compounds that can kill cancer cells on contact, while the outside molecular structure can be designed to bind to a specific protein that ensures precise delivery to only diseased tissue," Amanda Siegfried writes in UT Dallas Magazine.
